Arch Pharmalabs has acquired 70% of Benzochem Lifesciences for around $23m. Benzochem specialises in manufacturing oncology products.
In-Pharma Technologist
Thursday, 12 June 2008
Arch buys into Benzochem
Subscribe to:
Post Comments (Atom)
Arch Pharmalabs has acquired 70% of Benzochem Lifesciences for around $23m. Benzochem specialises in manufacturing oncology products.
In-Pharma Technologist
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
No comments:
Post a Comment